David Goel Matrix Capital Management Company
David Goel is a co-founder of Matrix Capital Management, a technology-oriented investment firm with public and private market activities. Matrix is known for concentrated positions in software, semiconductor, and internet-related businesses. Goel’s filings are monitored for high-conviction technology themes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Incyte
INCY
|
+$59.9M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$37.4M |
| 3 |
ADAP
Adaptimmune Therapeutics
ADAP
|
+$20.9M |
| 4 |
Amazon
AMZN
|
+$19.6M |
| 5 |
CyberArk
CYBR
|
+$16.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$86.6M |
| 2 |
O'Reilly Automotive
ORLY
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.71% |
| 2 | Communication Services | 27.83% |
| 3 | Technology | 22.95% |
| 4 | Consumer Discretionary | 7.78% |
| 5 | Industrials | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Netflix
NFLX
$257B
| $691M | 22.09% |
38,100,000
| – | – |
2013 Q2
17 quarters
|
|
2
Exelixis
EXEL
$17B
| $366M | 11.71% |
15,117,460
| – | – |
2016 Q4
3 quarters
|
|
3
Workday
WDAY
$45.9B
| $275M | 8.79% |
2,609,322
| – | – |
2013 Q2
17 quarters
|
|
|
4
Incyte
INCY
$24.8B
| $265M | 8.47% |
2,270,216
+473,500
| +26% | +$59.9M |
2016 Q2
5 quarters
|
|
5
TransDigm Group
TDG
$65.7B
| $184M | 5.87% |
717,783
| – | – |
2013 Q2
17 quarters
|
|
6
DELISTED
Pandora Media Inc
P
| $179M | 5.74% |
23,310,216
| – | – |
2016 Q1
6 quarters
|
|
|
NEWR
7
DELISTED
New Relic, Inc.
NEWR
| $156M | 4.98% |
3,125,281
| – | – |
2014 Q4
11 quarters
|
|
8
Constellation Brands
STZ
$24.5B
| $152M | 4.86% |
762,200
| – | – |
2013 Q4
15 quarters
|
|
|
DATA
9
DELISTED
Tableau Software, Inc.
DATA
| $150M | 4.81% |
2,007,000
| – | – |
2017 Q1
2 quarters
|
|
10
TripAdvisor
TRIP
$855M
| $149M | 4.76% |
3,675,600
+143,000
| +4% | +$5.81M |
2017 Q1
2 quarters
|
|
|
SGEN
11
DELISTED
Seagen Inc. Common Stock
SGEN
| $115M | 3.68% |
2,118,000
| – | – |
2016 Q4
3 quarters
|
|
12
DaVita
DVA
$10.9B
| $115M | 3.68% |
1,940,000
| – | – |
2013 Q2
17 quarters
|
|
|
ADAP
13
DELISTED
Adaptimmune Therapeutics
ADAP
| $98.6M | 3.15% |
12,043,511
+3,351,428
| +39% | +$20.9M |
2017 Q2
1 quarter
|
|
|
14
DELISTED
CyberArk
CYBR
| $77.1M | 2.47% |
1,880,500
+386,000
| +26% | +$16.4M |
2017 Q2
1 quarter
|
|
15
Under Armour Class C
UA
$2.04B
| $75.1M | 2.4% |
5,000,000
| – | – |
2017 Q1
2 quarters
|
|
|
ATVI
16
DELISTED
Activision Blizzard
ATVI
| $59.7M | 1.91% |
925,000
+600,000
| +185% | +$37.4M |
2017 Q2
1 quarter
|
|
|
17
Amazon
AMZN
$2.89T
| $19.2M | 0.61% |
+400,000
| New | +$19.6M |
2017 Q3
0 quarters
|
|
|
18
Salesforce
CRM
$179B
| – | – |
-1,000,000
| Closed | -$86.6M | – |
|
|
19
O'Reilly Automotive
ORLY
$73.4B
| – | – |
-1,845,000
| Closed | -$26.9M | – |
|
Similar funds
David Goel's Q3 2017 Portfolio in Review
As of Q3 2017, David Goel held 19 positions worth $3.13B, up 6.2% from $2.94B the previous quarter. Its ten largest holdings account for 82% of the portfolio.
David Goel's Q3 2017 filing shows 1 new, 5 increased and 2 closed positions. Its largest new stake was Amazon: 400,000 shares worth $19.2M. The largest sale was Salesforce, an estimated $86.6M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 30% a quarter earlier, followed by Communication Services and Technology.
- David Goel's largest Q3 2017 buy was Amazon: 400,000 shares worth $19.2M.
- David Goel added most to Incyte in Q3 2017, an estimated $59.9M increase.
- David Goel fully exited Salesforce in Q3 2017, selling an estimated $86.6M.
- David Goel's ten largest holdings make up 82% of its $3.13B portfolio in Q3 2017.
- David Goel opened 1 new position and closed 2 in Q3 2017.
- David Goel's portfolio value rose 6.2% quarter-over-quarter to $3.13B.
Based on Matrix Capital Management Company's 13F filing for Q3 2017, filed 14 Nov 2017.